Xiaoping Tu

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Xiaoping Tu is an author at First Affiliated Hospital of Zhengzhou University specializing in life sciences, immunology, and tumor antigen-based immunotherapy.

Publications per year

2022–2023

Publications

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy

Song Li, Dianze Chen, Huiqin Guo et al. · Antibody Therapeutics · 2023 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)

Jifeng Yu, Song Li, Dianze Chen et al. · Molecules · 2022 · 16 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

1–2 of 2